Autonomix Medical Inc近日宣布，其精准神经调控平台迎来重大扩展，核心是一份涵盖广泛的新美国专利，为神经感知、神经映射以及靶向治疗提供了坚实支撑。这一专利的获批，不仅保护了公司核心技术，更标志着其在神经调控领域迈出了关键一步。通过精准定位与感知神经信号，该平台有望显著提升治疗效率，为患者带来更个性化、更有针对性的医疗方案。
Autonomix Medical Inc近日宣布，其精准神经调控平台迎来重大扩展，核心是一份涵盖广泛的新美国专利，为神经感知、神经映射以及靶向治疗提供了坚实支撑。这一专利的获批，不仅保护了公司核心技术，更标志着其在神经调控领域迈出了关键一步。通过精准定位与感知神经信号，该平台有望显著提升治疗效率，为患者带来更个性化、更有针对性的医疗方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.